119th Congress
H.R. 1463
To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests", and for other purposes.
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Brad Finstad(R-MN)
- Introduced
- Feb 21, 2025
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce
- Official text
- Introduced in House · Congress.gov page
Cosponsors (7)
Original cosponsors (1)
- Dan Crenshaw (R-TX)
Added later (6)
- Mariannette Miller-Meeks (R-IA) · Feb 24, 2025
- Randy K. Weber, Sr. (R-TX) · Feb 27, 2025
- August Pfluger (R-TX) · Mar 4, 2025
- Neal P. Dunn (R-FL) · Mar 21, 2025
- Andy Barr (R-KY) · Apr 1, 2025
- Craig A. Goldman (R-TX) · Aug 8, 2025
Summary
Summary by the Congressional Research Service· describes the “Introduced in House” version
This bill prohibits the use of federal funds to implement, administer, or enforce the final rule issued by the Food and Drug Administration (FDA) titled Medical Devices; Laboratory Developed Tests and published on May 6, 2024, or any substantially similar rule.
The rule specifies that laboratory developed tests (medical screening tests developed by laboratories rather than medical device manufacturers) are medical devices subject to FDA regulation with limited exceptions. Prior to the rule, the FDA had exercised discretion as to whether to apply regulations for medical devices to laboratory developed tests.
Roll-call votes
No recorded votes on this bill.
Actions
- Feb 21, 2025 · House
Referred to the House Committee on Energy and Commerce. - Feb 21, 2025
Introduced in House